Bioequivalence Study in Patients With Schizophrenia by Using Clozaril 100 mg Tablet (Clozapine) and WID-CLZ18
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
This clinical study is a randomized, open label, multiple-dose, 2-way crossover, phase I
(Bioequivalence) study to compare the safety and pharmacokinetics profile of WID-CLZ18 and
Clozaril 100 mg tablet (Clozapine) after oral administration in schizophrenia patients.